Mouse CLEC4F/CLECSF13 Antibody | R&D Systems AF2784 product information

product summary

company name :

R&D Systems

product type :

antibody

product name :

Mouse CLEC4F/CLECSF13 Antibody

catalog :

AF2784

quantity :

100 ug (also 25 ug)

price :

489 USD

clonality :

polyclonal

host :

domestic goat

conjugate :

nonconjugated

reactivity :

human, mouse

application :

western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section

more info or order :

R&D Systems product webpage

citations: 24

Reference
Zhao D, Huang Z, Li X, Wang H, Hou Q, Wang Y, et al. GDF2 and BMP10 coordinate liver cellular crosstalk to maintain liver health. elife. 2024;13: pubmed publisher
Halimani N, Nesterchuk M, Tsitrina A, Sabirov M, Andreichenko I, Dashenkova N, et al. Knockdown of Hyaluronan synthase 2 suppresses liver fibrosis in mice via induction of transcriptomic changes similar to 4MU treatment. Sci Rep. 2024;14:2797 pubmed publisher
Katoch O, Ungalara R, Kaminski T, Li Z, Dubey R, Burholt I, et al. Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease. Biomedicines. 2023;11: pubmed publisher
Zheng L, Ling W, Zhu D, Li Z, Li Y, Zhou H, et al. Roquin-1 resolves sepsis-associated acute liver injury by regulating inflammatory profiles via miRNA cargo in extracellular vesicles. iScience. 2023;26:107295 pubmed publisher
Kim A, Kui L, Kaufmann B, Kim S, Leszczyńska A, Feldstein A. Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression. J Mol Med (Berl). 2023;101:813-828 pubmed publisher
Li L, Cui L, Lin P, Liu Z, Bao S, Ma X, et al. Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers. Cell Stem Cell. 2023;30:283-299.e9 pubmed publisher
Trzaskalski N, Vulesevic B, Nguyen M, Jeraj N, Fadzeyeva E, Morrow N, et al. Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression. JCI Insight. 2023;8: pubmed publisher
Mainz R, Albers S, Haque M, Sonntag R, Treichel N, Clavel T, et al. NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease. Cells. 2022;11: pubmed publisher
Guilliams M, Bonnardel J, Haest B, Vanderborght B, Wagner C, Remmerie A, et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell. 2022;185:379-396.e38 pubmed publisher
Cohen K, Mouhadeb O, Ben Shlomo S, Langer M, Neumann A, Erez N, et al. COMMD10 is critical for Kupffer cell survival and controls Ly6Chi monocyte differentiation and inflammation in the injured liver. Cell Rep. 2021;37:110026 pubmed publisher
Yang X, Lu D, Wang R, Lian Z, Lin Z, Zhuo J, et al. Single-cell profiling reveals distinct immune phenotypes that contribute to ischaemia-reperfusion injury after steatotic liver transplantation. Cell Prolif. 2021;54:e13116 pubmed publisher
Han Y, Onufer E, Huang L, Sprung R, Davidson W, Czepielewski R, et al. Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science. 2021;373: pubmed publisher
Ishikiriyama T, Nakashima H, Endo Umeda K, Nakashima M, Ito S, Kinoshita M, et al. Contrasting functional responses of resident Kupffer cells and recruited liver macrophages to irradiation and liver X receptor stimulation. PLoS ONE. 2021;16:e0254886 pubmed publisher
Daemen S, Chan M, Schilling J. Comprehensive analysis of liver macrophage composition by flow cytometry and immunofluorescence in murine NASH. STAR Protoc. 2021;2:100511 pubmed publisher
Jiang Y, Tang Y, Hoover C, Kondo Y, Huang D, Restagno D, et al. Kupffer cell receptor CLEC4F is important for the destruction of desialylated platelets in mice. Cell Death Differ. 2021;28:3009-3021 pubmed publisher
Tsitrina A, Krasylov I, Maltsev D, Andreichenko I, Moskvina V, Ivankov D, et al. Inhibition of hyaluronan secretion by novel coumarin compounds and chitin synthesis inhibitors. Glycobiology. 2021;31:959-974 pubmed publisher
Pilling D, Karhadkar T, Gomer R. A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet. PLoS ONE. 2020;15:e0244762 pubmed publisher
Remmerie A, Martens L, Thoné T, Castoldi A, Seurinck R, Pavie B, et al. Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver. Immunity. 2020;53:641-657.e14 pubmed publisher
Zhao Q, Molina Portela M, Parveen A, Adler A, Adler C, E H, et al. Heterogeneity and chimerism of endothelial cells revealed by single-cell transcriptome in orthotopic liver tumors. Angiogenesis. 2020;23:581-597 pubmed publisher
Verboom L, Martens A, Priem D, Hoste E, Sze M, Vikkula H, et al. OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- and RIPK1 Kinase-Mediated Hepatocyte Apoptosis. Cell Rep. 2020;30:2237-2247.e6 pubmed publisher
Hoyer F, Naxerova K, Schloss M, Hulsmans M, Nair A, Dutta P, et al. Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune Challenge. Immunity. 2019;51:899-914.e7 pubmed publisher
Bonnardel J, T Jonck W, Gaublomme D, Browaeys R, Scott C, Martens L, et al. Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche. Immunity. 2019;51:638-654.e9 pubmed publisher
Hage C, Hoves S, Ashoff M, Schandl V, H rt S, Rieder N, et al. Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy. PLoS ONE. 2019;14:e0219517 pubmed publisher
Kim K, Kim S, Han D, Jo Y, Lee Y, Lee M. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice. Sci Rep. 2018;8:6789 pubmed publisher

product information

brand :

R&D Systems

master code :

AF2784

SKU :

AF2784

product name :

Mouse CLEC4F/CLECSF13 Antibody

unit size :

100 ug (also 25 ug)

seo description :

The Mouse CLEC4F/CLECSF13 Antibody from R&D Systems is a goat polyclonal antibody to CLEC4F/CLECSF13. This antibody reacts with mouse,transgenic mouse. The Mouse CLEC4F/CLECSF13 Antibody has been validated for the following applications: Flow Cytometry,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence.

target :

CLEC4F/CLECSF13

category :

Primary Antibodies

buffer :

Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.

clonality :

Polyclonal

concentration :

LYOPH

conjugate :

Unconjugated

dilution :

Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL

host :

Goat

immunogen :

Mouse myeloma cell line NS0-derived recombinant mouse CLEC4F/CLECSF13, Ala65-Gly548, Accession # P70194

isotype :

IgG

purity :

Antigen Affinity-purified

species :

Mouse,Transgenic Mouse

specificity :

Detects mouse CLEC4F/CLECSF13 in direct ELISAs and Western blots.

gene symbol :

CLEC4F

top caption :

CLEC4F/CLECSF13 antibody in Mouse Liver by Immunohistochemistry (IHC-Fr).

accessionNumbers :

P70194

applications :

Flow Cytometry,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence

USD :

489 USD

alt names :

CLECSF13, C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 13, C-type lectin 13, C-type lectin domain family 4, member F, Galactose Particle Receptor, KCLR, KCR

storage :

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.

more info or order :

R&D Systems product webpage